British Inflammation Research Association Meeting: Is there any point in developing an anti-RA drug? National Heart and Lung Institute, London, UK, 21–22 November 1996

By Clay F.   Morris C.  

Inflammation Research, Vol. 46, Iss. 7, 1997-07 ,pp. : 243-245

Springer Publishing Company

Access to resources Recommend Favorite

The New Unified International Diabetes Federation/American Heart Association/National Heart, Lung, and Blood Institute Metabolic Syndrome Definition: Does It Correlate Better with C-reactive Protein in Chinese Patients Diagnosed with Type 2 Diabetes?

By Lu B   Zhang S   Wen J   Yang Y   Yang Z   Zhang Z   Wang X   Hu R  

The Journal of International Medical Research, Vol. 38, Iss. 6, 2010-11 ,pp. : 1923-1932

Field House Publishing

Access to resources Recommend Favorite

Pharmaceutical & Diagnostic Conferences, February – May 2004

By  

Pharmaceutical & Diagnostic Innovation, Vol. 1, Iss. 3, 2004-01 ,pp. : 60-63

Adis International

Access to resources Recommend Favorite

The US National Institute of Allergies and Infectious Diseases has granted $US10 million in funding to pharmaceutical company Baxter Healthcare to develop a vaccine against the coronavirus causing severe acute respiratory syndrome

By  

Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The Critical Path and Innovative Medicines Initiatives: 11 February 2009; London, England

By EllenderDr Donna  

Pharmaceutical Medicine, Vol. 23, Iss. 1, 2009-01 ,pp. : 57-60

Adis International

Access to resources Recommend Favorite